EyeGate Pharmaceuticals, Inc. financial reports, EyeGate Pharmaceuticals, Inc. annual revenue in 2024. When does EyeGate Pharmaceuticals, Inc. report revenue?
EyeGate Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of EyeGate Pharmaceuticals, Inc. on 31/03/2021 amounted to 0 $. EyeGate Pharmaceuticals, Inc. net income is now -2 580 821 $. The dynamics of EyeGate Pharmaceuticals, Inc. net income fell by -165 056 $ for the last reporting period. Graph of the financial report of EyeGate Pharmaceuticals, Inc.. All information on EyeGate Pharmaceuticals, Inc. total revenue on this chart is created in the form of yellow bars. A graph of the value of all EyeGate Pharmaceuticals, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-100 % ↓
-2 580 821 $
-396.371 % ↓
31/12/2020
12 059 $
-
-2 415 765 $
-
30/09/2020
0 $
-
-2 006 874 $
-
30/06/2020
0 $
-
-1 717 101 $
-
30/09/2019
0 $
-
-3 428 387 $
-
30/06/2019
0 $
-
-1 837 272 $
-
31/03/2019
2 686 000 $
-
870 809 $
-
31/12/2018
0 $
-
-2 528 005 $
-
30/09/2018
314 500 $
-
-3 123 836 $
-
30/06/2018
242 012 $
-
-2 780 255 $
-
31/03/2018
1 096 008 $
-
-2 379 327 $
-
31/12/2017
0 $
-
-2 831 032 $
-
30/09/2017
74 696 $
-
-4 140 368 $
-
30/06/2017
148 290 $
-
-3 326 863 $
-
Show:
to
EyeGate Pharmaceuticals, Inc. financial report charts
The dates of the latest financial statements of EyeGate Pharmaceuticals, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of EyeGate Pharmaceuticals, Inc. is available online for such a date - 31/03/2021. Gross profit EyeGate Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit EyeGate Pharmaceuticals, Inc. is -1 280 242 $
EyeGate Pharmaceuticals, Inc. quarterly report dates
Cost of revenue EyeGate Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue EyeGate Pharmaceuticals, Inc. is 1 280 242 $ Operating income EyeGate Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income EyeGate Pharmaceuticals, Inc. is -2 580 385 $ Net income EyeGate Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income EyeGate Pharmaceuticals, Inc. is -2 580 821 $
Current assets EyeGate Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets EyeGate Pharmaceuticals, Inc. is 6 991 086 $ Total assets EyeGate Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets EyeGate Pharmaceuticals, Inc. is 20 620 602 $ Current cash EyeGate Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash EyeGate Pharmaceuticals, Inc. is 6 610 492 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-1 280 242 $
-998 951 $
-985 880 $
-631 114 $
-2 406 129 $
-763 896 $
1 964 523 $
-1 437 254 $
-1 945 201 $
-1 595 787 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 280 242 $
1 011 010 $
985 880 $
631 114 $
2 406 129 $
763 896 $
721 477 $
1 437 254 $
2 259 701 $
1 837 799 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
12 059 $
-
-
-
-
2 686 000 $
-
314 500 $
242 012 $
1 096 008 $
-
74 696 $
148 290 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
2 686 000 $
-
314 500 $
242 012 $
1 096 008 $
-
74 696 $
148 290 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-2 580 385 $
-2 099 465 $
-2 007 205 $
-1 721 441 $
-3 451 274 $
-1 869 800 $
828 640 $
-2 489 456 $
-3 177 878 $
-2 798 318 $
-2 379 049 $
-4 172 729 $
-4 140 104 $
-3 326 794 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 580 821 $
-2 415 765 $
-2 006 874 $
-1 717 101 $
-3 428 387 $
-1 837 272 $
870 809 $
-2 528 005 $
-3 123 836 $
-2 780 255 $
-2 379 327 $
-2 831 032 $
-4 140 368 $
-3 326 863 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
-
-
2 521 009 $
3 077 178 $
3 175 978 $
2 262 193 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 580 385 $
2 111 524 $
2 007 205 $
1 721 441 $
3 451 274 $
1 869 800 $
1 857 360 $
2 489 456 $
3 492 378 $
3 040 330 $
3 475 057 $
4 172 729 $
4 214 800 $
3 475 084 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
6 991 086 $
1 810 149 $
3 497 603 $
5 197 459 $
3 112 880 $
5 127 889 $
6 658 825 $
8 478 433 $
10 581 314 $
13 234 636 $
5 328 331 $
8 459 305 $
10 228 566 $
12 446 482 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
20 620 602 $
15 157 559 $
9 245 100 $
10 966 902 $
8 867 615 $
10 895 542 $
12 439 396 $
14 280 617 $
16 652 082 $
19 064 791 $
11 166 452 $
14 305 392 $
16 059 413 $
18 313 431 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
6 610 492 $
1 185 677 $
2 931 349 $
4 688 961 $
2 454 577 $
4 465 086 $
5 855 966 $
8 004 237 $
9 900 094 $
12 604 803 $
3 693 308 $
7 851 029 $
9 244 570 $
11 763 137 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
2 175 993 $
943 817 $
919 944 $
3 864 382 $
4 157 935 $
4 120 697 $
9 624 $
11 214 $
12 645 $
12 645 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
3 648 308 $
7 806 029 $
9 244 570 $
11 763 137 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
3 655 961 $
2 423 785 $
2 399 912 $
5 344 350 $
5 551 998 $
5 516 332 $
12 907 $
16 069 $
19 230 $
22 391 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
41.23 %
22.25 %
19.29 %
37.42 %
33.34 %
28.93 %
0.12 %
0.11 %
0.12 %
0.12 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
12 684 959 $
6 999 500 $
5 961 312 $
7 797 563 $
5 211 613 $
8 471 716 $
10 039 443 $
8 936 226 $
11 100 043 $
13 548 418 $
5 278 018 $
-1 926 922 $
679 445 $
4 569 025 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-1 998 226 $
-1 422 423 $
-2 146 567 $
-2 003 516 $
-2 781 244 $
-1 945 029 $
-4 114 723 $
-1 453 310 $
-2 518 066 $
-2 478 564 $
Last revenue report of EyeGate Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in EyeGate Pharmaceuticals, Inc. was 0 US dollar and changed by -100% since last year. Net income in EyeGate Pharmaceuticals, Inc. was -2 580 821 $ in last quartal, net income changes to -396.371%.
EyeGate Pharmaceuticals, Inc. stocks data
EYEG stock price
EyeGate Pharmaceuticals, Inc. stock price today, EYEG stock quote.
